Vanda Pharmaceuticals Appoints Dr. Charles Duncan to its Board of Directors

B WASHINGTON, April 22, 2026 /PRNewswire/ — Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the appointment of Charles Duncan, Ph.D. to its Board of Directors…
posteditor
posteditor
Articles: 21727

Other News